The federal government has cracked down on illegal sales and dangerous marketing tactics surrounding GLP-1 compounds
It produced a mean body weight reduction of 24.2% over 48 weeks at a 12 mg dose in a phase II trial involving 338 adults with obesity, with more than half of the participants achieving at least 20% weight loss [10]
In June, Zealand released positive data from an early trial showing that a high dose of the drug helped people lose nearly 9 percent of their body weight on average at 16 weeks
Variations of GLP-1 drugs have become massively popular in recent years as injectable weight-loss medication.
No matter which medication you choose, there should be at least minimal safety measures to follow
Let's get to the bottom of why these plateaus happen while you're taking semaglutide, and, more importantly, how to get through them